Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcome.
Journal: Blood
Published: October 15, 2024
Impact of Genetic Ancestry on T-cell Acute Lymphoblastic Leukemia Outcomes.
Journal: Research square
Published: August 26, 2024
Cytosine base editing enables quadruple-edited allogeneic CART cells for T-ALL.
Journal: Blood
Published: February 07, 2022
Inhibition of the Sec61 translocon overcomes cytokine-induced glucocorticoid resistance in T-cell acute lymphoblastic leukaemia.
Journal: British journal of haematology
Published: January 12, 2022
Docetaxel, Oxaliplatin, and 5-Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long-Term Follow-Up.
Journal: The oncologist
Published: April 17, 2019
Can we downstage locally advanced pancreatic cancer to resectable? A phase I/II study of induction oxaliplatin and 5-FU chemoradiation.
Journal: Journal of gastrointestinal oncology
Published: December 04, 2018
Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer.
Journal: Cancer
Published: February 07, 2018
Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancer.
Journal: Investigational new drugs
Published: January 31, 2014
Cisplatin with capecitabine: tolerance and activity in a phase I/II study preferentially enrolling patients with gastric cancer.
Journal: Anticancer research
Published: March 09, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026